Benzimidazole tethered pyrrolo[3,4-b]quinoline with broad-spectrum activity against fungal pathogens
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 29 (5) , 729-733
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The Emerging Threat of Antifungal Resistance in Transplant Infectious DiseasesCurrent Infectious Disease Reports, 2018
- Invasive mold infections of the central nervous system in patients with hematologic cancer or stem cell transplantation (2000–2016): Uncommon, with improved survival but still deadly oftenJournal of Infection, 2017
- Design, synthesis and antiproliferative activity of decarbonyl luotonin analoguesEuropean Journal of Medicinal Chemistry, 2017
- Ebselen exerts antifungal activity by regulating glutathione (GSH) and reactive oxygen species (ROS) production in fungal cellsBiochimica et Biophysica Acta (BBA) - General Subjects, 2017
- Fungal Infections in Cancer Patients2014
- Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Annals of Hematology, 2013
- Recent insights into Candida albicans biofilm resistance mechanismsCurrent Genetics, 2013
- Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008Diagnostic Microbiology and Infectious Disease, 2012
- Candida albicans versus non-albicans bloodstream infections: The comparison of risk factors and outcomeJournal of Microbiology, Immunology and Infection, 2011
- Attributable mortality of candidemia: a systematic review of matched cohort and case-control studiesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006